OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
104
Results
Show all
Save search
Copy query
Show results for
Unknown
(103)
Proteomics
(1)
Repository
MassIVE
(1)
Instrument Platform
Orbitrap Eclipse
(1)
Orbitrap Fusion Lumos
(1)
Publication Date
2024
(1)
Release Date
2023
(12)
2020
(12)
2017
(11)
2025
(9)
2015
(9)
2021
(8)
2019
(7)
2024
(6)
2018
(6)
2016
(6)
2022
(5)
2014
(3)
2012
(3)
2026
(1)
2013
(1)
2011
(1)
2008
(1)
2007
(1)
2006
(1)
Previous
page
1 / 11
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
11
Next
page
Sort
by:
Relevance
Page size
10
Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.
Not available
S-EPMC4764423
|
biostudies-literature
Cite
Gait Speed as a Measure of Frailty and Outcomes After Lung Resection.
Not available
S-EPMC12857551
|
biostudies-literature
Cite
Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors.
Not available
S-EPMC8473487
|
biostudies-literature
Cite
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.
Not available
S-EPMC1941786
|
biostudies-literature
Cite
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905.
Not available
S-EPMC3986386
|
biostudies-literature
Cite
Effects of a change in recall period on reporting severe symptoms: an analysis of a pragmatic multisite trial.
Not available
S-EPMC11223809
|
biostudies-literature
Cite
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.
Not available
S-EPMC6209091
|
biostudies-literature
Cite
E3611-A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced Melanoma.
Not available
S-EPMC6335150
|
biostudies-literature
Cite
Phase II study of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy followed by yttrium-90-ibritumomab tiuxetan in untreated mantle-cell lymphoma: Eastern Cooperative Oncology Group Study E1499.
Not available
S-EPMC3732008
|
biostudies-literature
Cite
Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials.
Not available
S-EPMC10627528
|
biostudies-literature
Cite
Previous
page
1 / 11
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
11
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets